FDA Approved: GEMTESA — Original Application (Sumitomo Pharma America, Inc.)

View source ↗

Summary

FDA approved GEMTESA (vibegron) as an original application for the treatment of overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• GEMTESA (VIBEGRON)

Snippet

ORIG AP for GEMTESA (VIBEGRON)